Henderson Group »

Acelyrin shares owned by Henderson Group

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Henderson Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 1.6M 7.46
2023-09-30 $18M 1.8M 10.18

More positions owned by Henderson Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Workday Cl A (WDAY)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)
Adobe Systems Incorporated (ADBE)
Deere & Company (DE)
Abbvie (ABBV)

View all positions for Henderson Group

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin